Fresenius Medical Care AG KGaA Operating Margin 2010-2024 | FMS
Current and historical operating margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current operating profit margin for Fresenius Medical Care AG KGaA as of June 30, 2024 is 4.28%.
| Fresenius Medical Care AG KGaA Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-06-30 | $21.01B | $1.54B | 7.32% |
| 2024-03-31 | $21.13B | $1.47B | 6.95% |
| 2023-12-31 | $21.06B | $1.48B | 7.04% |
| 2023-09-30 | $20.82B | $1.39B | 6.66% |
| 2023-06-30 | $20.58B | $1.51B | 7.33% |
| 2023-03-31 | $20.38B | $1.48B | 7.27% |
| 2022-12-31 | $20.44B | $1.59B | 7.79% |
| 2022-09-30 | $20.63B | $1.74B | 8.44% |
| 2022-06-30 | $20.73B | $1.86B | 8.97% |
| 2022-03-31 | $20.87B | $2.01B | 9.63% |
| 2021-12-31 | $20.84B | $2.19B | 10.51% |
| 2021-09-30 | $20.79B | $2.24B | 10.76% |
| 2021-06-30 | $20.71B | $2.38B | 11.50% |
| 2021-03-31 | $20.53B | $2.59B | 12.63% |
| 2020-12-31 | $20.40B | $2.63B | 12.90% |
| 2020-09-30 | $20.21B | $2.76B | 13.65% |
| 2020-06-30 | $19.97B | $2.68B | 13.43% |
| 2020-03-31 | $19.83B | $2.55B | 12.83% |
| 2019-12-31 | $19.57B | $2.54B | 12.99% |
| 2019-09-30 | $19.40B | $2.55B | 13.15% |
| 2019-06-30 | $19.21B | $2.50B | 13.02% |
| 2019-03-31 | $19.35B | $3.59B | 18.53% |
| 2018-12-31 | $19.54B | $3.59B | 18.36% |
| 2018-09-30 | $19.87B | $3.51B | 17.68% |
| 2018-06-30 | $20.25B | $3.62B | 17.86% |
| 2018-03-31 | $20.14B | $2.59B | 12.84% |
| 2017-12-31 | $20.10B | $2.67B | 13.28% |
| 2017-09-30 | $19.55B | $2.84B | 14.51% |
| 2017-06-30 | $19.05B | $2.79B | 14.66% |
| 2017-03-31 | $18.55B | $2.79B | 15.04% |
| 2016-12-31 | $17.91B | $2.64B | 14.72% |
| 2016-09-30 | $17.57B | $2.51B | 14.30% |
| 2016-06-30 | $17.20B | $2.46B | 14.28% |
| 2016-03-31 | $16.98B | $2.36B | 13.91% |
| 2015-12-31 | $16.74B | $2.33B | 13.90% |
| 2015-09-30 | $16.71B | $2.33B | 13.93% |
| 2015-06-30 | $16.59B | $2.30B | 13.89% |
| 2015-03-31 | $16.23B | $2.31B | 14.25% |
| 2014-12-31 | $15.83B | $2.25B | 14.24% |
| 2014-09-30 | $15.38B | $2.25B | 14.63% |
| 2014-06-30 | $14.93B | $2.21B | 14.81% |
| 2014-03-31 | $14.71B | $2.19B | 14.87% |
| 2013-12-31 | $14.61B | $2.23B | 15.26% |
| 2013-09-30 | $14.45B | $2.12B | 14.70% |
| 2013-06-30 | $14.20B | $2.14B | 15.03% |
| 2013-03-31 | $14.02B | $2.16B | 15.43% |
| 2012-12-31 | $13.80B | $2.16B | 15.68% |
| 2012-09-30 | $13.42B | $2.19B | 16.31% |
| 2012-06-30 | $13.24B | $2.15B | 16.27% |
| 2012-03-31 | $13.01B | $2.10B | 16.11% |
| 2011-12-31 | $12.80B | $2.05B | 15.98% |
| 2011-09-30 | $12.64B | $2.01B | 15.90% |
| 2011-06-30 | $12.46B | $1.97B | 15.85% |
| 2011-03-31 | $12.21B | $1.94B | 15.88% |
| 2010-12-31 | $12.05B | $1.92B | 15.96% |
| 2010-09-30 | $11.92B | $1.87B | 15.71% |
| 2010-06-30 | $11.75B | $1.83B | 15.58% |
| 2010-03-31 | $11.57B | $1.78B | 15.42% |
| 2009-12-31 | $11.25B | $1.76B | 15.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.253B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.204B | 27.95 |
| Intuitive Surgical (ISRG) | United States | $171.750B | 97.25 |
| Alcon (ALC) | Switzerland | $47.924B | 33.74 |
| IQVIA Holdings (IQV) | United States | $43.748B | 24.79 |
| IDEXX Laboratories (IDXX) | United States | $42.163B | 50.72 |
| Edwards Lifesciences (EW) | United States | $40.499B | 25.96 |
| DexCom (DXCM) | United States | $27.626B | 39.39 |
| STERIS (STE) | Ireland | $23.834B | 27.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.222B | 0.00 |
| Waters (WAT) | United States | $19.528B | 29.11 |
| Hologic (HOLX) | United States | $19.046B | 20.71 |
| Sysmex ADR (SSMXY) | Japan | $12.644B | 39.65 |
| Teleflex (TFX) | United States | $11.376B | 17.69 |
| Globus Medical (GMED) | United States | $9.389B | 26.26 |
| Penumbra (PEN) | United States | $7.266B | 75.43 |
| Glaukos (GKOS) | United States | $6.681B | 0.00 |
| Masimo (MASI) | United States | $6.118B | 32.77 |
| TransMedics (TMDX) | United States | $5.207B | 222.97 |
| Integer Holdings (ITGR) | United States | $4.229B | 24.73 |
| PROCEPT BioRobotics (PRCT) | United States | $4.145B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.819B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.769B | 16.24 |
| Veracyte (VCYT) | United States | $2.636B | 163.43 |
| Inari Medical (NARI) | United States | $2.570B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.537B | 20.67 |
| Nihon Kohden (NHNKY) | Japan | $2.489B | 15.49 |
| RxSight (RXST) | United States | $2.076B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.331B | 6.06 |
| Pulse Biosciences (PLSE) | United States | $1.246B | 0.00 |
| OPKO Health (OPK) | United States | $1.158B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.110B | 19.80 |
| Artivion (AORT) | United States | $1.057B | 97.00 |
| Alphatec Holdings (ATEC) | United States | $0.836B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.664B | 16.78 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.644B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.619B | 0.00 |
| IRadimed (IRMD) | United States | $0.616B | 33.31 |
| Paragon 28 (FNA) | United States | $0.580B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.510B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.344B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.335B | 10.22 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.324B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.308B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.257B | 0.00 |
| Nevro (NVRO) | United States | $0.218B | 0.00 |
| NeuroPace (NPCE) | United States | $0.203B | 0.00 |
| Accuray (ARAY) | United States | $0.189B | 0.00 |
| CVRx (CVRX) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.182B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.178B | 12.47 |
| Alpha Tau Medical (DRTS) | Israel | $0.161B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.127B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.117B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.098B | 14.61 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.064B | 0.00 |
| Envoy Medical (COCH) | United States | $0.063B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.060B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| Lifeward (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |